(Q34111631)

31 July 2017

Unverricht-Lundborg disease with cystatin B gene abnormalities (English)

1 reference

31 July 2017

Kuriko Kagitani-Shimono

1

1 reference

31 July 2017

Katsumi Imai

2

1 reference

31 July 2017

Nobuhiko Okamoto

3

1 reference

31 July 2017

Jiro Ono

4

1 reference

31 July 2017

Shintaro Okada

5

1 reference

31 July 2017

1 January 2002

1 reference

31 July 2017

1 reference

31 July 2017

26

1 reference

31 July 2017

1

1 reference

31 July 2017

55-60

1 reference

"Baltic" myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

Novel cystatin B mutation and diagnostic PCR assay in an Unverricht-Lundborg progressive myoclonus epilepsy patient

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

The cystatins: Protein inhibitors of cysteine proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

The treatment of severe action myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

Effectiveness of piracetam in cortical myoclonus.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900336-8

7 January 2021

10.1016/S0887-8994(01)00336-8

Identifiers

DOI

1 reference

31 July 2017

1 reference